Geneva, Nov. 3 -- International Clinical Trials Registry received information related to the study (NCT07220213) titled 'FELLAShip to Better Health' on Oct. 21.
Study Type: Interventional
Study Design:
Allocation: Randomized. Intervention model: Crossover Assignment. Primary purpose: Prevention. Masking: None (Open Label).
Primary Sponsor: University of Alabama at Birmingham
Condition:
High Blood Glucose
High Cholesterol
High Cholesterol/Hyperlipidemia
Diabete Type 2
Blood Sugar
High
Obesity & Overweight
Intervention:
Behavioral: Black Impact
Recruitment Status: Not recruiting
Phase: N/A
Date of First Enrollment: January 1, 2026
Target Sample Size: 90
Countries of Recruitment:
United States
To know more, visit https://cl...